Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University Hospital, Basel, Switzerland
Study ID
NCT07777744
Status
Recruiting
Apply to this trial

Conditions

  • Premature Ventricular Complexes
  • Ventricular Tachycardia (VT)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The investigators aim to characterize patients presenting with a severe ventricular tachycardia (VT) and premature ventricular complex (PVC)-ablation-related complication including patient characteristics, procedural details and subsequent management of the complication by gathering existing patient-level data.

Key Dates

First listed
Aug 20, 2026
Start date
Jul 1, 2024
Status verified
Aug 2026
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
15,000 participants (estimated)

Primary Outcome Measure

Descriptive characterization of patients [ Time Frame: up to 30 days ]

Central Contacts

  • Michael Kühne, Prof. Dr. med.
    0041 61 265 52 14
    [email protected]
  • Patrick Badertscher, PD Dr. med.

Locations (2)

FacilityCityStateZIPSite coordinators
Rush University Medical CenterChicagoIllinois60612
Henry Huang
[email protected]
312-942-5000
University of MichiganMichigan CenterMichigan48109
Jackson Liang
[email protected]
734-936-4000

Find similar trials in Chicago, IL

By research site
Rush University Medical Center· Chicago, ILUniversity of Michigan· Michigan Center, MI

Related Studies